Market Place
Sourcing Support
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
17 May 2025 //
FIERCE PHARMA
Amgen`s Tepezza Granted Marketing Authorisation in UK for Thyroi
07 May 2025 //
BUSINESSWIRE
FDA lifts hold on Amgen`s phase 1 obesity study
03 May 2025 //
FIERCE BIOTECH
Amgen posts profit, says tax policy more effective than tariffs
02 May 2025 //
REUTERS
Amgen Report Q1 2025 Financial Result
01 May 2025 //
PR NEWSWIRE
Amgen`s Biologic Blincyto Receives Approval in US
29 Apr 2025 //
FDA
Amgen Announces Webcast for Q1 2025 Financial Results
28 Apr 2025 //
PR NEWSWIRE
Amgen to expand Ohio biotech manufacturing plant
26 Apr 2025 //
REUTERS
Amgen`s Biologic Bkemv Receives Suppl Approval in US
18 Apr 2025 //
FDA
Amgen`S 13-Year Ceo Robert Bradway Gains 8% Pay Hike To $24.4M
14 Apr 2025 //
FIERCE PHARMA
Sandoz sues Amgen over patient access to etanercept biosimilar
14 Apr 2025 //
GLOBENEWSWIRE
Imdelltra Shows Better Survival in Small Cell Lung Cancer
11 Apr 2025 //
PR NEWSWIRE
FDA approves Amgen`s Uplizna in IgG4-related disease
04 Apr 2025 //
ENDPOINTS
Enforcement Report - Week of March 26, 2025
26 Mar 2025 //
FDA
Amgen, Kyowa Kirin Report Ph3 Rocatinlimab Data In Atopic Dermatitis
08 Mar 2025 //
PR NEWSWIRE
Amgen’s late-stage obesity trials expected to read out in ‘27
08 Mar 2025 //
FIERCE BIOTECH
Tezspire Treats Chronic Sinus Symptoms With Nasal Polyps
03 Mar 2025 //
PR NEWSWIRE
AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
28 Feb 2025 //
PR NEWSWIRE
Amgen to invest $200 million in India site, CEO says
24 Feb 2025 //
ECONOMICTIMES
Drugmaker Amgen to invest $200 million in India site, CEO says
24 Feb 2025 //
REUTERS
Amgen to Present at CITI`S 2025 Virtual oncology leadership summit
14 Feb 2025 //
PR NEWSWIRE
Amgen, Ideaya Call It Quits on Cancer Combo
14 Feb 2025 //
BIOSPACE
Accumulus Synergy Powers 1st Digitally Generated Dossier Worldwide
05 Feb 2025 //
GLOBENEWSWIRE
Amgen’s early-stage obesity asset put on clinical hold by FDA
05 Feb 2025 //
FIERCE BIOTECH
Amgen Reports Report Q4 and Full Year Financial Result
04 Feb 2025 //
PR NEWSWIRE
EU Approves Blincyto® In CD19+ B-Cell ALL Consolidation Phase
29 Jan 2025 //
PR NEWSWIRE
Amgen fends off Celltrion`s proposed Prolia biosim until June
29 Jan 2025 //
FIERCE PHARMA
New Treatments for Celiac Disease Gain Traction
21 Jan 2025 //
BIOSPACE
New Treatments for Celiac Disease Gain Traction
20 Jan 2025 //
BIOSPACE
FDA Approves Lumakras & Vectibix Combo For G12C Colorectal Cancer
17 Jan 2025 //
PR NEWSWIRE
FDA approves Amgen`s colorectal cancer therapy
17 Jan 2025 //
REUTERS
Sling`s oral Tepezza rival hits goal in thyroid eye disease, Ph 3
15 Jan 2025 //
PR NEWSWIRE
Sling`s oral Tepezza rival hits goal in thyroid eye disease
14 Jan 2025 //
FIERCE BIOTECH
CytomX lays off 40%, mulls future of Amgen-partnered drug
10 Jan 2025 //
FIERCE BIOTECH
Amgen’s IMDYLLTRA Gets UK Approval For Extensive-Stage Lung Cancer
06 Jan 2025 //
BUSINESSWIRE
Amgen`s Biologic Kanjinti Receives Suppl Approval in US
19 Dec 2024 //
FDA
BeiGene inks $150M deal to follow cancer trail blazed by Amgen
14 Dec 2024 //
FIERCE BIOTECH
Amgen invests $1B in North Carolina manufacturing expansion
09 Dec 2024 //
BIOSPACE
Blincyto Improves Survival In Pediatric B-ALL With Chemotherapy
07 Dec 2024 //
PR NEWSWIRE
Amgen Stock Avoids Worst Day in 24 Years After Weight-Loss Data
27 Nov 2024 //
MARKETWATCH
Amgen`s weight-loss drug fails to impress in study; shares plunge
27 Nov 2024 //
REUTERS
Stanford`s Chang takes Amgen`s CSO reins from Bradner
20 Nov 2024 //
FIERCE BIOTECH
Amgen`s Biologic Repatha Receives Suppl Approval in US
20 Nov 2024 //
FDA
Amgen Presents New Data on Rare Inflammatory Diseases at ACR 2024
14 Nov 2024 //
PR NEWSWIRE
Amgen dismisses bone density concerns to its weight-loss drug
14 Nov 2024 //
REUTERS
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Amgen, AZ`s Tezspire excels in phase 3 rhinosinusitis trial
09 Nov 2024 //
FIERCE PHARMA
AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
08 Nov 2024 //
PR NEWSWIRE
Amgen reaps Horizon buyout rewards in Q3, preps biosim launches
31 Oct 2024 //
FIERCE PHARMA
Amgen Whets Investors’ Appetites for MariTide Obesity Data by EoY
31 Oct 2024 //
BIOSPACE
Amgen disappears lung disease program after phase 2 fail
31 Oct 2024 //
FIERCE BIOTECH
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
30 Oct 2024 //
PR NEWSWIRE
Amgen gears up to launch Eylea biosim as Regeneron plots appeal
23 Oct 2024 //
FIERCE PHARMA
AMGEN Presents Phase 3 Data For UPLIZNA® In Generalized Myasthenia
15 Oct 2024 //
PR NEWSWIRE
Amgen can`t sidestep investor lawsuit over $10.7B tax bill
02 Oct 2024 //
FIERCE PHARMA
La La Anthony Partners With Amgen on Plaque Psoriasis Insight
01 Oct 2024 //
PR NEWSWIRE
Amgen must face lawsuit claiming it hid $10.7 billion tax bill
01 Oct 2024 //
REUTERS
Amgen scores late trial success for eczema and MG treatments
25 Sep 2024 //
STATNEWS
Regeneron loses bid to block Amgen`s Eylea biosim, sinking shares
24 Sep 2024 //
FIERCE PHARMA
Amgen gets early win in Regeneron lawsuit over Eylea biosimilar
23 Sep 2024 //
REUTERS
